Pharma sector has been excluded from tariffs announced by the Trump administration
Unclear whether this is a short-term or medium-term arrangement
View it as positive for the sector if pharma is not targeted by tariffs
This aligns with our stance, where we have consistently assigned a low probability of tariffs on Indian pharma